Study held to see the effect of Chirbilva Ghanavati in hyperlipidemia

A Single arm clinical study to evaluate the efficacy of Chirbilva Ghanavati in the management of hyperlipidemia.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/03/051185

Enrollment

Registered

2023-03-29

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: patients of either sex.

Exclusion criteria

Exclusion criteria: 1.Patient is suffering with psychological disorder like anxiety , depression. 2.patient with renal ,hepatic, coronary heart disease. 3.pregnant women and lactating mothers.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of chirbilva ghanavati in reducing sr.cholestrol/LDL/VLDL.Timepoint: 1 month study with follow up on 0th and 30th day.	—

Secondary

Measure	Time frame
1.To study present day food habits and lifestyle as a causative factors for hyperlipidemia. Timepoint: 1 month study with follow up on 0th and 30th day.	—

Countries

India

Contacts

Public ContactDr Shubham Gajanan Yadav

Dr. D.Y. Patil College of Ayurved and Research Centre

gunvantayurved@gmail.com9028321955

Outcome results